ClinicalTrials.Veeva

Menu

Implementation of a Rehabilitation Technology in Orthopedic and Neurological Rehabilitation to Increase Therapy Dosage: an Exploratory Study

P

PXL University College

Status and phase

Unknown
Phase 2
Phase 1

Conditions

Arthroplasty
Neurologic Disorder

Treatments

Device: i-ACT

Study type

Interventional

Funder types

Other

Identifiers

NCT04906681
Exploration in St-Trudo

Details and patient eligibility

About

Rehabilitation technology is more and more implemented in conventional therapy to increase the dosage of therapy and/or increase patient's motivation towards therapy. In orthopedic as well as neurological rehabilitation it is important to exercise with enough intensity and repetitions to improve functional performance in activities of daily life, and consequently quality of life. At the moment, not all (rehabilitation) technologies are adapted towards the wishes and needs of both patients and therapists for everyday use in the clinical setting. Also, not all technologies are fit for independent use by the patients. Researcher of PXL have developed a Kinect-based system (i.e. i-ACT) for rehabilitation and performed supervised research with i-ACT in neurological and musculoskeletal rehabilitation, and older adults. Within this research, patients will exercise with i-ACT under supervision of their therapist during weekdays, but in the weekends they will be motivated by the medical staff to perform their exercises with i-ACT. The medical staff will be present for safety reasons, but the patient is asked to use and exercise with i-ACT as independent as possible. The aim of this research is to explore to which extend i-ACT is suitable for semi-independent use by patients in orthopedic or neurological rehabilitation.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age over 18 years old
  • post-operation of arthroplasty (hip or knee), or official medical diagnosis of stroke or Parkinson's disease
  • understand Dutch instructions
  • patient at St-Trudo ziekenhuis
  • experiencing problems in functional performance

Exclusion criteria

  • neglect
  • spasticity (Brunström Fugl-Meyer < 50)
  • cognitive disfunction (Mini Mental State Examination < 24)
  • visual impairment (blind, cataract, etc.)
  • persons who are not able to exit electric wheelchair

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Arthroplasty, hip or knee
Experimental group
Description:
Minimum 5x/week (of which minimal 3x/week with therapists and 2x/week during weekend), 30-60 minutes training, for 4 weeks, with i-ACT system. i-ACT provides individualised exercises based on patients own goalsetting.
Treatment:
Device: i-ACT
Neurology: stroke or Parkinson disease
Experimental group
Description:
Minimum 5x/week (of which minimal 3x/week with therapists and 2x/week during weekend), 30-60 minutes training, for 4 weeks, with i-ACT system. i-ACT provides individualised exercises based on patients own goalsetting.
Treatment:
Device: i-ACT

Trial contacts and locations

0

Loading...

Central trial contact

Els Knippenberg, MSc; Fitore Bajrami, BSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems